Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 50 of 284 from CROI 2014
Convener
John W. Mellors
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
Convener
Judith S. Currier
University of California Los Angeles, Los Angeles, CA, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
HIV Pathogenesis: Current Understanding and Future Research
Dana H. Gabuzda
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
HIV Cure Research
John W. Mellors
University of Pittsburgh, Pittsburgh, PA, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
HIV Vaccine Immunology: Recent Progress and Continuing Challenges
Richard A. Koup
Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
HIV Prevention Research: Progress and Challenges
Sharon L. Hillier
University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pittsburgh, PA, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
Pathogenesis and Control of HCV Infection
David L. Thomas
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2014 on March 3, 2014 9:00 AM-1:15 PM
Introduction
Michael Marco
Columbia University School of Public Health, New York, NY, United States
Panel Leader
Jeff Taylor
AIDS Treatment Activists Coalition, Palm Springs, CA, United States
Panel Leader
Tracy Swan
Treatment Action Group, New York, NY, United States
Panelist
Isabelle Andrieux-Meyer
Médecins sans Frontières, Geneva, Switzerland
Panelist
Jules Levin
National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
Panelist
Lynn E. Taylor
Brown University, Providence, RI, United States
Wrap-up
Jules Levin
National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
Questions and Answers
from CROI 2014 on March 3, 2014 1:30 PM-2:30 PM
Adherence: The Achilles Heel for Trial Interventions
David R. Bangsberg
Massachusetts General Hospital Center for Global Health, Boston, MA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Studying Multiple Interventions: Factorial Designs and Other Approaches
Richard J. Hayes
London School of Hygiene and Tropical Medicine, London, United Kingdom
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
So Many Trials, So Little Time: Meta-Analysis Dos and Don'ts
Dean A. Follmann
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Systems Immunology Approaches for Vaccine Profiling and Antibody Discovery
Sai Reddy
Swiss Federal Institute of Technology Zurich, Basel, Switzerland
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
3-D Structural Analysis of HIV Using Correlative CryoEM and Live Cell Imaging
Peijun Zhang
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Virus-Host Interactions Revealed Through Proteomics/Phosphoproteomics
Beatrix Ueberheide
New York University Langone Medical Center, New York, NY, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
CRISPRs and Other Genome Editing Systems
Paul F. Bates
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Convener
Robert T. Schooley
University of California San Diego, San Diego, CA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Liver Management
Kenneth E. Sherman
University of Cincinnati College of Medicine, Cincinnati, OH, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Interactive Case Presentations
David L. Wyles
University of California San Diego, San Diego, CA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Interactive Case Presentations
Susanna Naggie
Duke Clinical Research Institute, Durham, NC, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Interactive Case Presentations
David L. Wyles
University of California San Diego, San Diego, CA, United States
from CROI 2014 on March 3, 2014 2:30 PM-4:30 PM
Introduction
Kevin M. De Cock
Centers for Disease Control and Prevention, Nairobi, Kenya
from CROI 2014 on March 3, 2014 5:00 PM-7:00 PM
Bernard Fields Lecture: Making and Breaking Barriers To Cross-Species HIV-1 Transmission
Paul D. Bieniasz
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States
from CROI 2014 on March 3, 2014 5:00 PM-7:00 PM
N'Galy-Mann Lecture: Application of Scientific Knowledge and Evidence To Limit the Progression of HIV/AIDS and Fight Other Endemic Diseases in West Africa
Souleymane Mboup
Centre Hospitalier Universitaire Aristide le Dantec, Dakar, Senegal
from CROI 2014 on March 3, 2014 5:00 PM-7:00 PM
HPV Vaccines: Progress To Date and Future Worldwide Directions
Douglas R. Lowy
National Cancer Institute, Bethesda, MD, United States
from CROI 2014 on March 4, 2014 8:30 AM-9:00 AM
HIV in People Who Use Drugs
Adeeba Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
from CROI 2014 on March 4, 2014 9:00 AM-9:30 AM
Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals
Diana Y. Chen
Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C
Eric G. Meissner
Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4
Douglas Dieterich
Mount Sinai Medical Center, New York, NY, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)
Douglas Dieterich
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection
Trevor Hawkins
Southwest CARE Center, Santa Fe, NM, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)
Susanna Naggie
Duke Clinical Research Institute, Durham, NC, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial
Anita Kohli
Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection
Christophe Hezode
Hôpital Henri Mondor, Paris, France
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection
K Rajender Reddy
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1
Henning Hofmann
NYU School of Medicine, New York, NY, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
MX2, an Interferon-Induced Inhibitor of HIV-1 Infection
Melissa Kane
The Rockefeller University, New York, NY, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner
Ruth Serra-Moreno
Harvard Medical School, Southborough, MA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization
Markus-Frederik Bohn
Biochemistry, UMass Medical School, Worcester, MA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α
Owen Pornillos
Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis
Sebla B. Kutluay
Aaron Diamond AIDS Research Center, New York, NY, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors
Mirela D'arc
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)
Walid Heneine
Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Summary
Renate R. Köenig
Paul-Ehrlich-Institut, Langen, Germany
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Moderator
Victor G. Valcour
University of California San Francisco, San Francisco, CA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation
Julia Peterson
Neurology, University of California San Francisco, San Francisco, CA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV
Michael J. Peluso
Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Replication of HIV-1 in the Central Nervous System of Adults Early After Infection
Christa Buckheit Sturdevant
UNC Chapel Hill, Chapel Hill, NC, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression
Edward R. Hammond
The Johns Hopkins University, Baltimore, MD, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND
Edana Cassol
Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects
Ronald J. Ellis
University of California San Diego, San Diego, CA, United States
from CROI 2014 on March 4, 2014 10:00 AM-12:00 PM
Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility
Nikos Pantazis
Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece
from CROI 2014 on March 4, 2014 10:00 AM-12:15 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 50 of 284 from CROI 2014